Back

High-throughput fetal-fraction amplification increases analytical performance of noninvasive prenatal screening

2020-07-20 genetic and genomic medicine Title + abstract only
View on medRxiv
Show abstract

PurposeThe percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women with high body-mass index (and >5% overall) receive a test failure due to low FF (<4%). MethodsA scalable fetal-fraction amplification (FFA) technology was analytically validated on 1,264 samples undergoing whole-genome sequencing (WGS)-based NIPS. All ...

Predicted journal destinations